DONALD RICHARDS, MD
Medical Oncology Physician · TYLER, TX
Individual Active NPI 1659313559
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 766 | 117,546 | $9,510,216 | $2,700,701 | $2,148,832 |
| 2023 | 927 | 163,593 | $13,846,736 | $3,830,899 | $3,052,721 |
| 2022 | 956 | 187,563 | $12,011,400 | $3,226,368 | $2,577,095 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 10,200 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 10,100 | $56 | $44 |
| J9267 | Injection, paclitaxel, 1 mg | 7,068 | $0 | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 6,000 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 5,550 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 4,700 | $0 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 4,635 | $3 | $2 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 3,725 | $0 | $0 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,990 | $47 | $37 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,761 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 1,020 | $26 | $21 |
| 36415 | Insertion of needle into vein for collection of blood sample | 769 | $9 | $9 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | G7424 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1194019075
- NPI 1174566624
- NPI 1346331063
- NPI 1497319636
- NPI 1346323888
- NPI 1447414776
- NPI 1063676245
- NPI 1730463324
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.